Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
about
Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosaA novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative BacteriaWhy is Pseudomonas aeruginosa a pathogen?Evaluation of a microarray-hybridization based method applicable for discovery of single nucleotide polymorphisms (SNPs) in the Pseudomonas aeruginosa genomeShanghai fever: a distinct Pseudomonas aeruginosa enteric disease.Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system.Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomesManagement of Pseudomonas aeruginosa pneumonia: one size does not fit allPathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patientsSynthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).Innate immune responses to Pseudomonas aeruginosa infection.Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif.Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa.N-3-(oxododecanoyl)-L-homoserine lactone promotes the induction of regulatory T-cells by preventing human dendritic cell maturation.Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype.Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cellsMatrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.The type III secretion system of Pseudomonas aeruginosa: infection by injection.Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?Update on the treatment of Pseudomonas aeruginosa pneumonia.Emerging themes of cAMP regulation of the pulmonary endothelial barrier.Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.Structure and function of the Type III secretion system of Pseudomonas aeruginosa.Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation.Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.Recently published papers: Pseudomonas, brain and bowel injury and novel cardiac therapiesClinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii.Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.Pseudomonas aeruginosa: so many virulence factors, so little time.Pseudomonas aeruginosa: an uninvited guest refuses to leave.PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.Increased claudin-3, -4 and -18 levels in bronchoalveolar lavage fluid reflect severity of acute lung injury.
P2860
Q27346512-DA957D96-6BC5-4B1C-938E-21D7AE82DC7BQ30408273-ADE5EBC3-6754-4904-9DAC-F4E2C839064DQ30431366-9A7122D0-9FAA-403B-8CA3-EF4018C9D8A4Q30434529-B48767CE-BB24-4E7C-AD88-CCF840B1F66AQ33400850-392B9A70-E3CD-4C40-ACF0-F42741D583BDQ33409776-50166E4E-2A2A-4D0D-903D-5E7B80226651Q33622815-802AE0DA-7EC4-4162-8CDF-8934718EE28DQ33754176-E3CD4C30-BD2D-4AA9-9F83-25BED0BFCD0CQ33754588-9EDB2F10-F549-463A-8578-3C08421DA659Q33769060-4143E922-7F05-465E-A5CE-D628D972D392Q33807598-4D4023E8-C404-423C-AF70-31DC2989952EQ34384649-200C7863-93F0-492A-A3CB-E99C6AA03544Q34478058-F5137FB7-994A-4034-A07B-FB604D6CDC71Q35118409-7216AE68-0539-4BB3-9AFC-75103420A5E0Q35566398-45EAE741-6D95-4CF4-9AA0-AA285283F20CQ35783999-F1C2CAB7-0F0E-41D5-AB83-732251C1678BQ36614104-71B49003-3F8D-476D-874E-0D2B06EC0C1CQ37036553-0B25379F-B245-4032-9D4C-B5F0580D7DBAQ37071542-EE539536-2A99-45ED-8AE3-DFBB3BDB1700Q37306380-C2816C7C-BC07-4665-9040-F2D3994A675CQ37358382-E91D0B70-2D8A-46ED-9D14-347089D13317Q37372512-9F43E1B8-1809-45BF-8037-B618CFBE5D9DQ37373550-CF255B27-7BB6-45E2-9BAF-F6B448B1F5F9Q37397923-C3523DB2-7DC8-44D4-A3DE-870EFF8AFA68Q37402651-C57AE88C-1957-4D7B-8D06-0E2054650568Q37516904-39A674CE-A168-433D-888A-5E049EDD3F05Q37845025-F159968C-4C83-4EC9-A9A5-6E46501020C6Q38058355-C6068DC1-A353-4C38-A6BC-61F9670D8CD7Q38072996-9674E7E0-39D4-49B0-9712-5C99F50F3D49Q38210320-1C3E2684-B980-4C64-98D6-2CF35AD7CD09Q40605168-B7B51645-05D2-4945-BA56-D369E00BB731Q41399311-B2AD2BDA-EA98-49D3-8287-1039F4CEBD9FQ42276769-3D555423-DA2A-48F3-8BE2-3F001EADD9D1Q42287771-6912C2AF-A07A-4C80-8415-CE3B2CC5DD1EQ42855404-D0EA3D16-10D9-4A92-8529-59009AD82FB8Q42906503-E8EB63A7-3573-4B9A-A169-87AE8334E949Q43181958-708EE4FD-3C98-41C0-A490-6B11F2BCF1F1Q43446661-71243614-1F35-4A80-B262-C27A031B7540Q43472217-8CCB9FAA-8CE1-428C-8F0B-396A018309CEQ44228192-79810A88-DF16-480B-B271-57299949400E
P2860
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
@en
type
label
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
@en
prefLabel
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
@en
P2093
P2860
P921
P1476
Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.
@en
P2093
Ali A El Solh
Jeanine P Wiener-Kronish
Kristie Szarpa
Lilibeth A Pineda
Morohunfolu E Akinnusi
Susan V Lynch
P2860
P304
P356
10.1164/RCCM.200802-239OC
P407
P577
2008-05-08T00:00:00Z